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Six members of the microRNA-17 (miR-17) family were mapped to
three different chromosomes, although they share the same seed
sequence and are predicted to target common genes, among
which are those encoding hypoxia-inducible factor-1α (HIF1A) and
VEGFA. Here, we evaluated the in vivo expression profile of the
miR-17 family in the murine retinopathy of prematurity (ROP)
model, whereby Vegfa expression is highly enhanced at the early
stage of retinal neovascularization, and we found simultaneous
reduction of all miR-17 family members at this stage. Using gene
reporter assays, we observed binding of these miRs to specific
sites in the 3′ UTRs of Hif1a and Vegfa. Furthermore, overexpres-
sion of these miRs decreased HIF1A and VEGFA expression in vitro.
Our data indicate that this miR-17 family elicits a regulatory syn-
ergistic down-regulation of Hif1a and Vegfa expression in this bi-
ological model. We propose the existence of a coordinated regula-
tory network, in which diverse miRs are synchronously regulated to
target the Hif1a transcription factor, which in turn, potentiates and
reinforces the regulatory effects of the miRs on Vegfa to trigger
and sustain a significant physiological response.
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MicroRNAs (miRs) are among the most important post-transcriptional regulators of gene expression and affect
several normal biological processes, such as the cell cycle and cell
fate determination during development, including angiogenesis.
Recently, a large body of literature identified and confirmed a
number of miRs that regulate angiogenesis (1–8).
In humans, the miR-17 family is composed of six distinct
mature miRs located on three chromosomes: miR-17–5p and
miR-20a are located on chromosome 13q31.3, miR-20b and miR-
106a are located on chromosome Xq26.2, and miR-106b and
miR-93 are located on chromosome 7q22.1. Members of this family
seem to be derived from gene duplication events (9), and despite
some divergences in length and nucleotide composition, their seed
sequence (AAAGUG) is identical, an attribute suggestive of func-
tional redundancy (10). Although the miR-17–92 cluster has been
well-characterized, the regulatory role of the miR-17 family mem-
bers has not been extensively studied (11, 12). Distinct prediction
algorithms (13–16) indicate that the miR-17 miR family may target
the 3′ UTRs of genes encoding hypoxia-inducible factor-1α
(HIF1A) and VEGFA. Therefore, by simultaneously targeting
these two key genes, miR-17 family members could, in theory, be
important concerted regulators of angiogenesis. As proof of
concept, we tested this hypothesis in the experimental mouse model
of retinopathy of prematurity (ROP), where Vegfa seems to be
a pivotal factor that modulates the angiogenic switch (17–19). In this
model, the expression of retinal VegfamRNA increases sharply 12 h
after the animals are returned from 75% oxygen (O2) back to room
air (∼21% O2), a process that induces a relative hypoxic condition
and leads to retinal neovascularization in the subsequent 9 d (17–19).
Here, we show the synchronous down-regulation of all mem-
bers of the miR-17 family in the critical early steps of neo-
vascularization in the ROPmodel.We propose anmiR regulatory
network, in which distinct and partially redundant miR-17 family
members simultaneously affect the levels of the Hif1a transcrip-
tion factor to posttranscriptionally (either directly and/or indi-
rectly) increase the expression of one of its key downstream
targets (i.e., Vegfa) (20–22), thereby influencing the physiological
response to retinal hypoxia.
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Retinal angiogenesis is a finely tuned biological phenomenon
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members that share the same seed sequence. These results
identify potential therapeutic targets in eye diseases with ab-
normal retinal angiogenesis.
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Results and Discussion
Retinal Angiogenesis and miR Expression. The O2-induced retinal
neovascularization model (17–19) has been widely used to study the
molecular mechanisms of blood vessel formation during relative
hypoxia. Here, we used this model to address the putative role of
miR-17 family members in the early steps of the angiogenic switch
(Fig. 1). This particular family was selected, because all six members
were predicted to target Hif1a and Vegfa mRNA using different
algorithms, albeit not experimentally confirmed. Mapping miR-17
family members to the 3′ UTRs of Hif1a and Vegfa transcripts
showed that the target sites were located in regions conserved in
mammals, avians, and amphibians (Fig. 2), strongly indicating that
these regions may, indeed, be targets for regulatory molecules.
We assumed that the time for the angiogenic switch to be
triggered overlaps with maximum Vegfa expression. Because we
intended to evaluate the regulation of Vegfa expression by the
miR-17 family, experimental time points were selected from the
established peak of Vegfa expression in this model (18). As
expected, retinal neovascularization was observed in 21-d-old
mice that were exposed to high O2 levels for 5 d and removed to
room air thereafter (Fig. 1 A–C). This vascular response was
consistent with previous reports (17–19), and with the noteworthy
increase in Vegfa expression (ANOVA, P = 1.83 × 10−15) that was
apparent 12 h after the animals were returned to room air (Fig.
1D). To document further the mimicry of hypoxia in this model
and its effects on the expression of hypoxia miR surrogates, we
evaluated the amounts of two hypoxia-induced miRs, miR-210 and
miR-296, whose induction had been shown in other hypoxia models
(23–27).We observed a consistent increase in bothmiRs (ANOVA,
P = 1.15 × 10−11 and P = 4.76 × 10−16, respectively) after 12 h of
induced relative hypoxia (Fig. 1E), thus confirming these miRs as
general and robust molecular biomarkers of hypoxia. We in-
vestigated whether the levels of miR-17 family members were af-
fected at two time points relative to maximal Vegfa expression (i.e.,
at 6 and 12 h after high O2 exposure). Our real-time PCR results
showed a significant reduction of all six members of the miR-17
family after 12 h of relative hypoxia (ANOVA, P < 0.05) (Fig. 1E).
Validation of miR Targeting. The observed down-regulation of all
miRs of this family after 6 and 12 h post-O2 exposure led us to
evaluate their regulatory capabilities using luciferase reporter
assays of the putative targets Hif1a and Vegfa mRNA. Luciferase
expression levels were compared from WT Hif1a and Vegfa with
mutated controls that contain a 7-nt deletion within the predicted
3′ UTR regulatory binding sequence. Both WT and mutated 3′
UTR regions were tested with or without miR transfection.
Transfection of each miR resulted in a significant reduction of
luciferase activity compared with the control in the presence of
WT 3′ UTR-targeted regions from both Hif1a and Vegfa; on the
contrary, luciferase activity was increased in the presence of each
miR-17 RNA when either Hif1a or Vegfa contained a 7-nt de-
letion within the 3′ UTR region (Fig. 3) (ANOVA, P < 0.05).
Fig. 1. Angiogenesis and Vegfa expression in the murine ROP model. (A) Seven-day-old pups and their mothers were transferred to 75% oxygen for 5 d.
After this period, animals were returned to room air (∼21% O2) and subsequently killed at time 0, 6, or 12 h. (B and C) As a control for retinal neo-
vascularization, some animals were kept alive until postnatal day 21, when new blood vessel sprouts (indicated by arrows) were observed in retinas of animals
that were exposed to high O2 levels. (D) Levels of Vegfa mRNA increased after 6 and 12 h in room air compared with Vegfa mRNA from animals killed
immediately (deemed 0 h time point) after transfer to room air. (E) miR variations at 6 and 12 h relative to those from animals killed immediately after their
return to room air O2. At 12 h, the increase of Vegfa was accompanied by an augmentation of miR-210 and miR-296 (established hypoxia-induced miRs) as
well as reduced expression of all miR-17 family members. The dots represent the minimum (green), median (black), and maximum (red) fold variations
observed for each miR relative to control. P values were calculated by using ANOVA. miRNA, miR. **P < 0.01.
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These results indicate that themiR-17 family members bind to the
predicted 3′ UTR region, and by doing so, they regulate the ex-
pression of both Hif1a and Vegfa.
miR-17 Family Members Regulate HIF1A and VEGFA Expression. To
recapitulate in vitro the regulatory events observed in vivo, we
used human Y79 retinoblastoma cells, which develop from im-
mature retinas containing amacrine interneurons and Mu ̈ller
glial cells (28). Y79 cells express VEGFA, and Mu ̈ller glial cells
are especially active in the mouse neovascularization model (19).
We observed reduced levels of HIF1A by ELISA (Fig. 4A) after
transfecting cells with miR-20a (P = 0.02), miR-93 (P = 0.01),
miR-106a (P = 1.04 × 10−5), and miR-106b (P = 0.04). Similarly,
VEGFA levels decreased by 30% (ANOVA, P < 0.05) compared
with baseline levels (Fig. 4B) after cell transfection with four
of six family members [namely, miR-17–5p (P = 0.02), miR-20b
(P = 0.005), miR-93 (P = 0.02), and miR-106b (P = 0.001)]. These
results are consistent with our working hypothesis that Hif1a and
Vegfa expressions are regulated by the miR-17 family during the
early stages of the angiogenic switch in the ROP model.
Low Levels of miR-17 Family in the Initial Steps of the Angiogenic
Switch. The discovery of miR regulation has added another di-
mension to the genetic study of cancer (29). This report corrob-
orates this concept by extending the role of the miR-17 family to
early angiogenic events, an important initial step in tumor pro-
gression. Because each miR can theoretically bind to and regulate
hundreds of targets, one of the most intriguing questions concerns
the translational regulation of the target genes (30). In the ROP
model, we observed a consistent reduction of all six miR-17 family
members and a corresponding increase in Hif1a and Vegfa pro-
tein levels within hours after mice pups were returned to room air
after 5 d of high O2 exposure. Conversely, the higher intracellular
concentration of these miRs in transfected Y79 cells resulted in
a substantial reduction of VEGFA transcript and HIF1A and
VEGFA protein expression. Theoretically, the effective trigger for
angiogenesis—achieved after HIF1A and VEGFA up-regulation—
would require simultaneous reduction of all of its negative reg-
ulators. Because these miRs share the same seed sequence, we
expected—and observed—a similar response for each family
member. Although a single miR is able to repress the production
of hundreds of proteins, the cumulative effect may be relatively
mild (31). In this case, finely tuned and complex biological pro-
cesses, such as angiogenesis, require the concerted, simultaneous
silencing of all miR-17 family members to bias the biological
signals that ultimately lead to blood vessel formation.
In a previous study, Shen et al. (32) investigated miR alter-
ations by microarray analysis using the ROP model. Shen et al.
(32) evaluated a later time point (3 d after high O2 exposure on
day 15 vs. 6 and 12 h on day 12 as studied here), when the events
that lead to Hif1a and Vegfa up-regulation have already oc-
curred. Shen et al. (32) identified the levels of five miR-17 family
members (miR-17–5p, miR-20a, miR-20b, miR-106a, and miR-
106b) increased at this later time point. We also tested the ex-
pression levels of all miR members from the miR-17 family at
this same time point using a more sensitive and specific approach
(quantitative RT-PCR). In our hands, only miR-20b and miR-106b
levels increased at this time point, whereas the expression levels of
the other four members were down-regulated (data not shown).
It should be noted that the capability of some of the miR-17
family members to regulate VEGF and HIF1A expressions has
been shown. For instance, the inhibition of miR-20b led to an
incremental increase of HIF1Α and VEGF protein levels in nor-
moxic tumor cells, whereas the increase of miR-20b in hypoxic
tumor cells decreased the levels of these two proangiogenic pro-
teins (33). This study is the first demonstration, to our knowledge,
of the simultaneous down-regulation of all miRs of the miR-17
Fig. 2. Alignment of HIF1A, and VEGFA genes shows highly conserved 3′ UTRs. VISTA (visualization tool for alignment) alignments of human, mouse, and rat
(A) HIF1A and (B) VEGFA genes show similar 3′ UTRs together with TargetScan predictions of putative miR binding sites. miR target regions used for gene
reporter assays are shown as black bars for both genes. (C) The strong conservation of the putative miR binding site in this region is shown in the detailed
alignment of the miR-17–5p seed sequence to compare the 3′ UTR from mammals, avians, and amphibians.
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family in the early time interval that precedes up-regulation of
these important proangiogenesis factors.
We propose here that the simultaneous down-regulation of all
miR-17 family members stimulates a positive cumulative effect on
Hif1a and Vegfa expressions. When hypoxia supervenes after 5 d of
high oxygen exposure, the induction of Hif1a expression seemed
to increase by decreased levels of the miR-17 family. Lower levels
of miR regulators would positively and simultaneously affect Hif1a
and Vegfa protein levels. Higher Hif1a levels would certainly
support higher Vegfa levels and probably contribute to drive the
early steps of the angiogenic switch. These events could initiate
a cascade that leads to consistent physiological responses without
requiring additional quantitative alterations of miRs. This regula-
tion scenario may not be exclusive to this miR family and these
target genes. In this sense, Martinez et al. (34) describe an miR
regulatory network in Caenorhabditis elegans of experimentally
mapped interactions among transcription factors and miRs.
Angiogenesis is a multistep process that occurs over an ex-
tended period. As a tightly regulated physiological event, angio-
genesis is a central biological phenomenon and a target for
therapy in diseases, such as different forms of retinopathy and
cancer, among other conditions. In this study, the importance of
using an established, reproducible in vivo model was crucial to
assess the complexity within an actual tissue microenvironment
without the interference of artificial variables from an in vitro
model. The reduction of all miR-17 family members simulta-
neously in the hypoxic retina as well as other tissues and tumors
might be an early response to contextual signals within the tissue
microenvironment that triggers neovascularization. In this context,
it is interesting to note that overexpression of some of the miRs
evaluated here (namely miR-17 and miR-20a) inhibits metastasis
(also an angiogenesis-dependent process) in pancreatic carcinoma
cells (35) as well as breast cancer (36).
The physiologic response to hypoxia is complex. The manip-
ulation of individual miRs in arbitrary concentrations and in vitro
is unlikely to recreate this complex phenomenon. The hypoxia
response and regulation of neovascularization by a limited set of
miRs seem to be a short-duration, context-dependent process. As
shown in Fig. 1E, all miRs evaluated in this study exhibited
a significant decrease 12 h after the animals were returned to
normoxia (ANOVA, P < 0.01). Of these miRs, miR-93 and miR-
106a have been described as hypoxia-regulated miRs in cells ex-
posed to hypoxic conditions (0.2% O2) in vitro (7), but the miRs
documented in this study showed an opposite trend in vivo. Al-
though some studies showed that the levels of some of the miR-17
family members increase in solid tumors, others have shown de-
letion of genomic loci encoding these same miRs (37). In this cell
context-dependent manner, Doebele et al. (38) show that over-
expression of some members from the miR-17 cluster (miR-17;
miR-18a, miR-19a, and miR-20a) leads to a decrease of endo-
thelial cells sprouts in vitro. Conversely, in the same study, down-
regulation of theses miRs in vivo, particularly miR-17/miR-20,
increases neovascularization but did not affect tumor angiogen-
esis. This observation is in accordance with our data and indicates
that miR expression can, therefore, be expected to be specific in
different cell types and physiological situations and thus, is con-
text-dependent (39).
Fig. 3. Regulation of Hif1a and Vegfa mRNAs by miR-17 family members.
Gene reporter assays of (A) Hif1a or (B) Vegfa expression containing WT or
mutated regions of the mouse 3′ UTR show that members of the miR-17 family
bind to specific 3′ UTRs of these genes and regulate luciferase activity. Analyses
were performed after 24 h of transfection using 10 nM each miR. miRNA, miR.
Statistical significances are *P < 0.05, **P < 0.01, and ***P < 0.001.
Fig. 4. miR-17 family members regulate HIF1A and VEGFA expression.
Proteins derived from Y79 retinoblastoma cells transfected with each of the
miR-17 RNAs show that each member of the miR-17 family decreased the
levels of (A) HIF1A or (B) VEGFA expression as determined by ELISA. Analyses
were performed after 24 h of transfection using 10 nM each miR. miRNA,
miR. Statistical significances are indicated as *P < 0.05 and **P < 0.01.
Nunes et al. PNAS | March 24, 2015 | vol. 112 | no. 12 | 3773
M
ED
IC
A
L
SC
IE
N
CE
S
Another interesting analogous study showed significant down-
regulation of miR-200b, an miR that targets Vegfa, in a mouse
model of diabetic retinopathy (40). In this model, high blood glu-
cose levels lead to down-regulation of miR-200 with subsequent
up-regulation of Vegfa mRNA and Vegfa expression resulting in
increased vascular permeability in vitro and in vivo.
This report puts forth a model in which the regulation of hyp-
oxia-related genes by the miR-17 family occurs in tandem. Small
reductions in the levels of miRs of all members of this family
would lead to an incremental increase in Hif1a. Both higher Hif1a
and lower miR levels subsequently trigger higher levels of Vegfa
expression. This angiogenic cascade may have even broader
effects, because some of these miRs have been shown to regulate
CTGF and TBSP1 (both of which have proangiogenic properties)
and are also predicted to target at least 14 additional angiogen-
esis-related genes (16) as well as another 5 genes recently pre-
dicted to be regulated by HIF1A (41, 42) (Fig. 5). Thus, it is
conceivable that coordinated regulation of some of these genes by
diminution of the miR-17 family levels might be an early step that
leads to angiogenesis (Fig. 5). Within a larger context, it is in-
teresting to note that hypoxia is also a well-known regulator of
angiogenesis in cancer. Indeed, because poorly vascularized areas
in solid tumors are hypoxic and low O2 levels contribute to radi-
ation therapy resistance (43), the miR regulation described here
coupled with the hypoxic tumor microenvironment could trigger
the angiogenic switch. This presumed key event occurs before
blood vessel development to restore homeostasis and is required
for solid tumor growth. Additionally, an even earlier event might
be hypoxia-induced increase of p53 to suppress miR-17 elements
at the transcriptional level by p53 binding to a specific site in the
proximal region of the miR-17 promoter to competitively inhibit
binding of a TATA binding protein transcription factor within an
overlapping site in the promoter region (44). Thus, a tantalizing
role of the miR-17 family to regulate tumor angiogenesis remains
an open question to be addressed in future studies.
In conclusion, we present three previously unrecognized find-
ings. First, we show a decrease of all miR-17 family members in the
in vivo ROP mouse model of angiogenesis. Second, we show that
these miRs bind to the 3′ UTRs of Hif1a and Vegfa and reduce the
expression levels of these gene products after transfection into Y79
cells in vitro. Third, the miR-17 family members seem to be one of
the earliest hypoxia-responsive molecular elements identified so far
that triggers the angiogenic switch as part of an as yet unrecognized
regulatory network of functional interactions.
Materials and Methods
ROP Model. Seven-day-old C57BL/6 pups and their mothers were kept in 75%
O2 for 5 d, after which the animals were transferred to room air and killed at
6 and 12 h thereafter (Fig. 1A). Experiments were performed in duplicate
with two independent O2 chambers. On average, five mice (i.e., 10 retinas)
were used for each time point (0, 6, or 12 h) in each chamber as described
(17–19). Retinas were immediately dissected under a stereomicroscope and
kept in RNAlater (Ambion) at 4 °C until the RNA was extracted. Four animals
from each chamber as well as four controls (i.e., not exposed to 75% O2)
were maintained until postnatal day 21 as negative controls for neo-
vascularization. The Animal Care and Use Committee of the University of
Texas M. D. Anderson Cancer Center approved all experiments (Animal Pro-
tocol 119909934). This study strictly adheres to the guidelines from the As-
sociation for Research in Vision and Ophthalmology statement.
RNA Extraction and Analysis. miRs and mRNAs were extracted using reagents
from the mirVana miRNA Kit (Ambion). Selected miRs and mRNAs were
quantified by real-time PCR with TaqMan microRNA Qssays (Applied Biosystems)
or SybrGreen (sequences of primers and probes are available on request).
snoRNA-202 and snoRNA-234 were used as endogenous controls for adjusting
the expression of the miRs by real-time quantitative analysis. For mRNA
quantification, the β-glucuronidase gene served as the endogenous control.
Gene Reporter Assays. The predicted 3′ UTR target regions of both Vegfa
and HIF1A genes, which contain the putative miR binding sites for miR-17 family
members, were amplified by PCR, cloned downstream of the luciferase coding
sequence in the pGL3 vector (Promega), and confirmed by DNA sequencing
before transfection into COS-1 cells (4 × 104 cells per well in 96-microwell plates;
ATCC). Plasmids containing mutated target regions were generated by deleting
7 nt in the miR binding sites using the QuikChange XL Site-DirectedMutagenesis
Kit (Agilent Technologies). Plasmid constructs (100 ng per well) were cotrans-
fected with Renilla luciferase pRL-CMV vector (2 ng per well) in the absence or
presence of each miR-17 family member (n = 6) at a final concentration of
30 nM. Normalized luciferase ratios were determined 24 h after transfection
using the Dual-Glo Luciferase Reporter-Assay System (Promega). All experiments
were performed three times and contained 10 biological replicates each.
miR Transfections. Human Y79 retinoblastoma-derived cells (4 × 105 cells per
well; ATCC) were transfected with Lipofectamine 2000 (Invitrogen) in 12-well
plates with each of the six miRs from the miR-17 family. Distinct time points
(3, 6, 12, and 24 h) as well as various miR concentrations (3, 10, and 30 nM)
were tested to evaluate the effects of miR transfection on the levels of HIF1A
and VEGFA expression relative to negative controls. Off-target effects and
specificity of the selected miRs were further evaluated using the nontargeted,
Cy5-labeled control 1 miR (Ambion) at the same time points and concentrations.
Posttransfection levels of HIF1A and VEGFA expression were determined using
an ELISA DuoSet Kit (R&D Systems). For HIF1A quantification, cells were lysed
with RIPA buffer, and HIF1A levels were determined from 35 mg total resulting
protein. Secreted VEGFA was determined from 15 mL Y79 cell-conditioned
media. All experiments were repeated at least three times in triplicate.
Statistical Analysis.One-way ANOVAwas used to assess the significance of the
differences between groups. The criterion used for significance was P < 0.05.
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Fig. 5. Working hypothesis schematic. miR-17 family members bind to and
negatively regulate Hif1a expression, which also affects Vegfa expression
and other proangiogenesis genes. These miRs also simultaneously down-
regulate Vegfa expression, which directly affects angiogenesis. Because these
miRs might also regulate other proangiogenesis genes, it is likely that fluc-
tuations in miR levels would affect angiogenesis because of its action on
many different targets.
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